Resonant Clinical Solutions Expands Advanced-Therapy and Cryogenic Storage Capabilities with Acquisition of Creapharm Bioservices

▤ Summary

Resonant Clinical Solutions acquired France-based Creapharm Bioservices from Myonex. The deal expands Resonant’s European biorepository footprint and adds cryogenic storage and specialized handling for biotherapeutics, ATMPs, and biological samples. The company says the acquisition strengthens support for cell and gene therapy trials and other complex clinical programs. Financial terms were not disclosed. The transaction also helps Myonex refocus on its core business strategy.

▦ Linked Companies

IQVIA

$1B+